William W Kwok Selected Research

MART-1 Antigen

10/2009	Tumor antigen-specific FOXP3+ CD4 T cells identified in human metastatic melanoma: peptide vaccination results in selective expansion of Th1-like counterparts.
11/2006	Melan-A/MART-1-specific CD4 T cells in melanoma patients: identification of new epitopes and ex vivo visualization of specific T cells by MHC class II tetramers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

William W Kwok Research Topics

Disease

32	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 12/2023 - 11/2003
21	Human Influenza (Influenza) 07/2023 - 09/2002
16	Neoplasms (Cancer) 01/2022 - 09/2002
16	Infections 01/2021 - 11/2007
9	Hypersensitivity (Allergy) 01/2019 - 09/2010
7	Rheumatoid Arthritis 12/2021 - 10/2010
7	Melanoma (Melanoma, Malignant) 01/2021 - 09/2002
6	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 11/2003
5	Disease Progression 07/2023 - 10/2002
5	COVID-19 01/2023 - 11/2020
4	Celiac Disease (Celiac Sprue) 01/2021 - 08/2006
4	Asthma (Bronchial Asthma) 01/2020 - 12/2015
4	Lyme Disease (Disease, Lyme) 04/2008 - 04/2006
3	Inflammation (Inflammations) 01/2022 - 03/2014
3	Multiple Sclerosis 11/2020 - 07/2011
3	Communicable Diseases (Infectious Diseases) 11/2020 - 01/2003
3	Testicular Neoplasms (Testicular Cancer) 01/2018 - 05/2004
3	Peanut Hypersensitivity (Peanut Allergy) 01/2018 - 05/2011
3	Seasonal Allergic Rhinitis (Hay Fever) 04/2014 - 02/2012
3	Arthritis (Polyarthritis) 04/2008 - 04/2006
2	Cardiovascular Diseases (Cardiovascular Disease) 05/2022 - 11/2018
2	Atherosclerosis 05/2022 - 11/2018
2	Vasculitis (Vasculitides) 01/2022 - 01/2020
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 11/2020
2	Blast Crisis (Blast Phase) 01/2021 - 11/2020
2	Yellow Fever 01/2020 - 12/2013
2	Allergic Rhinitis 01/2019 - 01/2018
2	Tuberculosis (Tuberculoses) 05/2015 - 05/2012
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2014 - 09/2002
2	Viremia 02/2010 - 10/2003
1	Common Cold 01/2023
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022
1	Atopic Dermatitis (Atopic Eczema) 01/2022
1	Skin Neoplasms (Skin Cancer) 10/2019
1	Retinoblastoma (Glioblastoma, Retinal) 10/2019
1	Merkel Cell Carcinoma 10/2019

Drug/Important Bio-Agent (IBA)

44	Peptides (Polypeptides)IBA 01/2023 - 01/2002
34	EpitopesIBA 07/2023 - 09/2002
34	AntigensIBA 07/2023 - 09/2002
19	Proteins (Proteins, Gene)FDA Link 01/2023 - 09/2003
14	AutoantigensIBA 07/2023 - 11/2003
10	HLA-DR Antigens (HLA-DR)IBA 01/2022 - 04/2006
10	AllergensIBA 01/2020 - 09/2010
8	Insulin (Novolin)FDA Link 01/2020 - 11/2005
7	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 01/2021 - 08/2006
6	T-Cell Antigen Receptors (T-Cell Receptor)IBA 12/2021 - 08/2004
6	CytokinesIBA 11/2021 - 04/2010
5	Immunodominant EpitopesIBA 07/2023 - 01/2002
5	VaccinesIBA 10/2019 - 07/2003
5	Hemagglutinins (Hemagglutinin)IBA 01/2019 - 11/2005
4	NucleoproteinsIBA 01/2022 - 09/2003
4	HLA-DQA1 antigen (HLA DQA1)IBA 11/2020 - 02/2006
4	Amino Acids FDA Link 11/2020 - 01/2017
4	Antiviral Agents (Antivirals)IBA 01/2020 - 05/2007
4	ProinsulinIBA 01/2019 - 11/2005
4	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 01/2018 - 05/2004
4	Tetanus ToxinIBA 04/2010 - 09/2005
4	Anti-Bacterial Agents (Antibiotics)IBA 04/2008 - 04/2006
3	HLA-DQ Antigens (HLA-DQ)IBA 11/2020 - 01/2017
3	Indicators and Reagents (Reagents)IBA 01/2020 - 10/2002
3	HLA-DQ8 antigenIBA 01/2019 - 08/2006
3	HLA-DRB1 Chains (HLA DRB1)IBA 01/2019 - 10/2010
3	OspA proteinIBA 01/2008 - 04/2006
2	HLA-DR alpha-ChainsIBA 07/2023 - 08/2009
2	preproinsulinIBA 07/2023 - 01/2017
2	Apolipoproteins B (ApoB)IBA 05/2022 - 11/2018
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2022 - 01/2020
2	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2018
2	Immunoglobulin G (IgG)IBA 11/2021 - 12/2015
2	Interleukin-2 (IL2)IBA 01/2021 - 10/2003
2	Glutens (Glutelin)IBA 01/2021 - 08/2006
2	HLA-DRB1*04:01 antigenIBA 10/2019 - 11/2007
2	HLA-DRB3 Chains (HLA DRB3)IBA 01/2019 - 01/2018
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2019 - 11/2018
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 08/2011
2	AutoantibodiesIBA 01/2019 - 05/2002
2	Immunoglobulin E (IgE)IBA 01/2018 - 12/2015
2	Neoplasm Antigens (Tumor Antigens)IBA 01/2018 - 10/2009
2	hypoxanthine arabinoside (ara-H)IBA 01/2018 - 05/2011
2	Interleukin-10 (Interleukin 10)IBA 05/2015 - 09/2010
2	Monophenol Monooxygenase (Tyrosinase)IBA 01/2013 - 05/2004
2	Interleukin-4 (Interleukin 4)IBA 05/2011 - 09/2010
2	Viral AntigensIBA 06/2010 - 09/2003
2	MART-1 AntigenIBA 10/2009 - 11/2006
1	ApolipoproteinsIBA 05/2022
1	Myeloblastin (Proteinase 3)IBA 01/2022
1	Fibronectins (Fibronectin)IBA 01/2022
1	Carrier Proteins (Binding Protein)IBA 01/2022
1	HLA-DR3 Antigen (HLA DR3 Antigen)IBA 01/2022
1	HLA-DPB1 antigen (HLA DPB1)IBA 01/2022
1	TenascinIBA 12/2021
1	serum P-component (CIt)IBA 12/2021
1	HLA-DR15 antigenIBA 11/2020
1	Peroxidase (Myeloperoxidase)IBA 01/2020
1	CitrullineIBA 01/2020
1	Oncogene Proteins (Oncogene Protein)IBA 10/2019

Therapy/Procedure

12	Therapeutics 07/2023 - 11/2007
10	Immunotherapy 01/2019 - 01/2003
1	Drug Therapy (Chemotherapy) 01/2021
1	Induction Chemotherapy 11/2020